Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 101 - 110 of 190

Selected Filters:
15 February 2023

Incorporating End-users’ Voices into the Development of an Implant for HIV Prevention: A discrete choice experiment in South Africa and Zimbabwe

This article from BMC Women’s Health describes the results of a discrete choice experiment undertaken with adolescent girls and young women in South Africa and Zimbabwe where participants were asked their preferences for a hypothetical HIV prevention implant.

Research

External Link
13 February 2023

PrEP Disclosure and Discussions within Social Networks of People who Inject Drugs Experiencing Homelessness: A brief report

This article from BMC Public Health examines social experiences surrounding PrEP use among people who inject drugs experiencing homelessness in Boston, Massachusetts, USA.

Research

External Link
13 February 2023

Integrating Pre-exposure Prophylaxis of HIV Infection into Family Planning Services: A scoping review

This scoping review from BMJ Sexual and Reproductive Health maps evidence of integrating PrEP into family planning services to identify barriers and enablers of integrating services at the client-level and provider-level.

Research, Service Delivery

External Link
6 February 2023

Optimizing Uptake of Long-Acting Injectable Pre-exposure Prophylaxis for HIV Prevention for Men Who Have Sex with Men

This article from AIDS and Behavior describes the results of a discrete choice experiment on preferences for oral or injectable PrEP amongst gay, bisexual, and other men who have sex with men in the USA, including mode of administration, side-effects, monetary cost, and time cost.

Research

External Link
6 February 2023

Pregnancy and Neonatal Safety Outcomes of Timing of Initiation of Daily Oral Tenofovir Disoproxil Fumarate and Emtricitabine Pre-exposure Prophylaxis for HIV Prevention (CAP016): An open-label, randomised, non-inferiority trial

This article from The Lancet HIV describes the results of a trial to compare pregnancy and neonatal outcomes in women exposed and not exposed to oral PrEP (TDF/FTC) during pregnancy in Durban, South Africa.

Research

External Link
1 February 2023

Discontinuation of Government Subsidized HIV Pre-exposure Prophylaxis in Australia: A whole-of-population analysis of dispensing records

This article from the Journal of the International AIDS Society examines the impact of discontinuation on overall PrEP usage, the proportion of PrEP users who discontinue and the predictors of discontinuation in Australia.

Monitoring & Evaluation, Research

External Link
30 January 2023

HIV Pre-exposure Prophylaxis (PrEP) Knowledge among General Practitioners in 2020: A French survey

This article from Infectious Diseases Now analyses the knowledge of and position on PrEP amongst general practitioners in Hauts-de-France, France.

Service Delivery

External Link
30 January 2023

An Update on Expanding HIV Preexposure Prophylaxis

This article from the Journal of the American Academy of Physicians Assistants describes how to better employ PrEP in the United States in light of changes to the Centers for Disease Control guidelines on PrEP counselling, monitoring, and delivery, and approval of injectable cabotegravir for PrEP by the US Food and Drug Administration.

Monitoring & Evaluation, Normative Guidance/Policies, Service Delivery

External Link
30 January 2023

Same-day Initiation of Oral Pre-exposure Prophylaxis among Gay, Bisexual, and Other Cisgender Men who Have Sex with Men and Transgender Women in Brazil, Mexico, and Peru (ImPrEP): A prospective, single-arm, open-label, multicentre implementation study

This article from The Lancet HIV assesses the feasibility of same-day oral PrEP delivery amongst gay and bisexual men who have sex with men and transgender women in Brazil, Mexico, and Peru.

Service Delivery

External Link
23 January 2023

Cost-effectiveness Analysis of the Daily HIV Pre-exposure Prophylaxis in Men who Have Sex with Men in Barcelona

This article from PLOS One models the cost-effectiveness of daily oral PrEP use amongst gay and bisexual men who have sex with men in Barcelona, Spain.

Financing & Costing, Research

External Link